Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  HCP, Inc.    HCP

Delayed Quote. Delayed  - 06/24 10:01:17 pm
34.23 USD   +0.35%
06/25 FINAL NOTICE : Khang & Khang LLP Announces The Filing Of A Securitie..
06/25 HCP SHAREHOLDER : Kahn Swick & Foti, LLC Reminds Investors with Loss..
06/24 Levi & Korsinsky, LLP Reminds Shareholders of HCP, Inc. of Class ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1002 266-2 5392 5872 592
Operating income (EBITDA)1 7081 343-7681 7441 7001 743
Operating profit (EBIT)1 296883-5881 2611 2041 010
Pre-Tax Profit (EBT)852-----
Net income969920-561686684797
P/E ratio17,122,0-31,623,921,627,6
EPS ( $ )2,132,00-1,211,431,591,24
Dividend per Share ( $ )2,102,182,262,272,272,42
Yield5,78%4,95%5,91%6,64%6,62%7,08%
Reference price ( $ )36.3244.0338.2434.2334.2334.23
Announcement Date02/11/2014
01:00pm
02/10/2015
01:00pm
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt---9 9699 6819 152
Finance------
Operating income (EBITDA)1 7081 343-7681 7441 7001 743
Leverage
(Debt/EBITDA)
---5,72x5,69x5,25x
Capital Expenditure195503-65,565,8-
Book Value Per Share (BVPS)23,5 $23,4 $20,1 $19,4 $18,9 $17,8 $
Cash Flow per Share2,52 $2,69 $2,64 $2,68 $2,63 $2,85 $
Announcement Date02/11/2014
01:00pm
02/10/2015
01:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 15 988 M$ -
Entreprise Value (EV) 25 957 M$ 25 670 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 23,9x 21,6x
Capitalization / Revenue 6,30x 6,18x
EV / Revenue 10,2x 9,92x
EV / EBITDA 14,9x 15,1x
Yield (DPS / Price) 6,64% 6,62%
Price to book (Price / BVPS) 1,77x 1,81x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 49,7% 46,5%
operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) 27,0% 26,4%
ROA (Net Profit / Asset) 3,45% 3,95%
ROE (Net Profit / Equities) 8,55% 8,69%
Rate of Dividend 159% 143%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   2,58% 2,54%
Cash Flow / Sales 49,3% 47,4%
Capital Intensity (Assets / Sales) 7,84x 6,69x
Financial Leverage (Net Debt / EBITDA) 5,72x 5,69x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend